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Pharmaceuticals Co., Ltd., Beijing, China; 5Saw Swee Hock School of Public Health, National University of Singapore, SingaporeA B S T R A C TObjective: To generate a Chinese general population–based three-
level EuroQol ﬁve-dimensios (EQ-5D-3L) social value set using the
time trade-off method. Methods: The study sample was drawn from
ﬁve cities in China: Beijing, Guangzhou, Shenyang, Chengdu, and
Nanjing, using a quota sampling method. Utility values for a subset of
97 health states deﬁned by the EQ-5D-3L descriptive system were
directly elicited from the study sample using a modiﬁed Measurement
and Valuation of Health protocol, with each respondent valuing 13 of
the health states. The utility values for all 243 EQ-5D-3L health states
were estimated on the basis of econometric models at both individual
and aggregate levels. Various linear regression models using different
model speciﬁcations were examined to determine the best model
using predeﬁned model selection criteria. Results: The N3 model
based on ordinary least square regression at the aggregate level
yielded the best model ﬁt, with a mean absolute error of 0.020, 7 and 0
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597.respectively, in absolute magnitude. This model passed tests for model
misspeciﬁcation (F ¼ 2.7; P ¼ 0.0509, Ramsey Regression Equation
Speciﬁcation Error Test), heteroskedasticity (χ2 ¼ 0.97; P ¼ 0.3254,
Breusch-Pagan/Cook-Weisberg test), and normality of the residuals (χ2 ¼
1.285; P ¼ 0.5259, Jarque-Bera test). The range of the predicted values
(0.149 to 0.887) was similar to those estimated in other countries.
Conclusions: The study successfully developed Chinese utility values for
EQ-5D-3L health states using the time trade-off method. It is the ﬁrst
attempt ever to develop a standardized instrument for quantifying
quality-adjusted life-years in China.
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Cost-utility analysis (CUA) is an increasingly used form of
economic evaluation in health technology assessment. In CUA,
health outcomes are measured using a single common measure,
quality-adjusted life-years (QALYs), which is based on both
life-years and the quality of life gained during the life-years.
The quality of life for QALY calculation should be measured
on a utility scale on which 1.0 corresponds to full health and
0.0 corresponds to death. Utility of health outcomes can be
directly measured using the visual analog scale, time trade-off
(TTO), or standard gamble method; however, these elicitation
methods are difﬁcult for both researchers and respondents. An
alternative approach is to use the preference-based health-
related quality of life instruments [1]. Examples are the Health
Utilities Index [2,3], three-level EuroQol ﬁve-dimensions (EQ-5D-
3L) [4], ﬁve-level EQ-5D [5], and the Short-Form six-dimensions
(SF-6D) derived from the short-form 36 health survey [6].
The EQ-5D-3L is a simple but widely used instrument in CUA.
It provides utility values for a total of 243 unique health states
described using a system comprising ﬁve dimensions (i.e.,mobility, self-care, usual activities, pain/discomfort, and anxi-
ety/depression) and three levels (i.e., 1 ¼ no problems, 2 ¼ some/
moderate problems, and 3 ¼ extreme problems) for each dimen-
sion. The utility values for the EQ-5D-3L health states are
measured from the general population using TTO. With such
values available, the utility of any health outcome can be derived
simply by describing the health outcome using the EQ-5D-3L
system. Because the utility of EQ-5D-3L health states may be
affected by culture [7,8], many countries such as the United
Kingdom, the United States, and Japan have developed their
national EQ-5D-3L value sets.
The EQ-5D-3L has been recommended as a tool for conducting
health technology assessment in China by China Guidelines for
Pharmacoeconomic Evaluations 2011 [9] and its descriptive system,
the EQ-5D-3L self-report questionnaire, has been validated in
Chinese populations [10–12]. The application of the EQ-5D-3L
questionnaire in China, however, is restricted because there was
no Chinese value set. The purpose of this study was to establish
an EQ-5D-3L value set for China using TTO values for 97 EQ-5D-3L
health states directly elicited from the general population
in China.ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
BY-NC-ND license
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Sampling Design
A convenience general population sample was recruited from ﬁve
cities of China: Beijing, Guangzhou, Shenyang, Nanjing, and
Chengdu. The cities are roughly located in centers of the most
populous areas of the nation including north, northeast, east, south,
and southwest. The target sample size for each city was 240, and
quotas were set to make sure that the age and sex distributions of
the sample resembled those of the national Chinese population in
2009 [13]. Age and sex were found to be the major demographic
characteristics affecting health preferences [14,15].
The Valuation Interview
One-on-one, face-to-face interviews were conducted by trained
interviewers in the homes of participants. The Paris protocol [16],
which represented an improvement of the Measurement and
Valuation of Health (MVH) protocol [17], was used in this study.
After a brief introduction to the purpose of the study, the inter-
viewer asked the respondents to complete the following tasks: 1)
describe their own health using the EQ-5D-3L questionnaire
descriptive system; 2) rank 13 EQ-5D-3L health states in terms of
their severity; 3) rate the 13 health states using a vertical, hash-
marked visual analog scale; 4) answer the TTO questions designed
for the 13 health states (i.e., TTO valuation exercise); and 5) answer
questions assessing sociodemographic and health characteristics.
As in previous studies of this kind, tasks 1 to 3 were used to
familiarize participants with the health states. Each health state
was presented in a separate card on which text describing the
health state was printed, and a visual aid was used in the TTO
exercise to illustrate the different lengths of hypothetical lives. In
the TTO valuation exercise, participants were ﬁrst asked to rate
whether a health state was better than, equivalent to, or worse
than death. If a state was considered better than death, a series of
questions were asked to ﬁnd out the number of years (t) at which
the respondent was indifferent between t years of life in full
health and 10 years of life in that state. The TTO value for that
state was estimated as t/10 (0 o t r 10). The TTO value for states
considered as bad as death was 0. If a state was considered worse
than death, the number of years (t) at which the respondent was
indifferent between a life of (10  t) years in that state followed by
t years in full health and death was elicited using a series of
questions. The TTO value was t/(10  t).Table 1 – Health states valued by block and severity.
Severity Block A Block B Block C Block
Mild 11112 11221 11212 2221
12122 11222 12211 2121
12112 11122 12121 1121
Moderate 31213 11313 12123 2133
31311 32123 21313 2113
23132 21311 12313 3312
21123 11323 23313 2222
23231 33121 33313 1312
22113 33211 33231 1122
Severe 22233 23233 33332 3323
22332 23322 32322 2332
23333 33222 32223 3332
Anchor 33333 33333 33333 3333
Note. The ﬁrst to the ﬁfth digit in each vector represents mobility, self-
number 1, 2, and 3 represents no problems (level 1), some or moderateThe survey was performed from March 11 to May 25, 2011. A
total of 106 faculty members, and graduate and undergraduate
students recruited from ﬁve universities located in the study sites
were used as interviewers. All the interviewers participated in a
standard training workshop and practiced their interview skills in
mock interviews with each other and in a pilot study.
Selection of Health States for Valuation
Each EQ-5D-3L health state can be coded into a ﬁve-digit number
using the numbers 1 (no problems), 2 (some/moderate problems),
and 3 (extreme problems) to indicate the functional levels of the ﬁve
dimensions of mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression in the state. For example, 21223 stands for a
state of having some problems in mobility and usual activities,
moderate pain/discomfort, and extreme anxiety/depression.
As in a previous study conducted by Lee et al. [15], we followed
the Paris protocol proposed by Paul Kind rather than the MVH
protocol to select EQ-5D-3L health states to be valued. Based on the
assumption that more health states would provide better estima-
tion, the Paris protocol proposed to directly value a total of 101 EQ-
5D-3L health states for estimating a EQ-5D-3L value set. In the
present study, we included 97 of those health states and divided
them into eight blocks, with each block comprising three “mild”
states, 6 “moderate” states, and 3 “severe” states (Table 1). Mild
states were health states in which dimensions were either in level 1
(no problems) or in level 2 (some/moderate problems) such as the
state 12221; severe states were health states in which dimensions
were either in level 2 or in level 3 (extreme problems) such as the
state 33222; all other EQ-5D-3L states were considered as moderate
states. In this study, each participant was randomly assigned one
block of states plus the state 33333 for valuation.
Data Analysis
Transformation of negative values
We rescaled negative TTO values to the range from 1 to 0. The
purpose of this procedure was to eliminate the “outlier” effects of
extreme low values in subsequent linear regression modeling
and data aggregation. The lowest possible value that our valu-
ation protocol allowed was 19. It occurred when a participant
preferred immediate death to a life of 1 year in a poor health state
followed by 9 years of full health. In this case, we assumed that
the value of 0.5 years in that health state followed by 9.5 years of
full health is equivalent to death. Three transformation methods
were used [18] to bound negative values to a minimum of 1 forD Block E Block F Block G Block H
1 21111 12221 22111 11121
1 22121 21121 22112 21122
1 21112 21221 12212 12111
2 21331 11332 12312 23321
3 11123 13222 13211 21231
2 22232 12331 23311 11232
1 11312 33221 32111 21312
3 13232 31222 22313 31131
3 23222 33312 23131 31313
3 33223 32332 33232 22333
3 33323 23223 23332 22323
2 32233 32333 32323 32232
3 33333 33333 33333 33333
care, usual activities, pain/discomfort, and anxiety/depression. The
problems (level 2), and extreme problems (level 3), respectively.
V A L U E I N H E A L T H 1 7 ( 2 0 1 4 ) 5 9 7 – 6 0 4 599states worse than death, namely, monotonic, linear, and trunca-
tion transformation. Because none of the methods is rooted in
any utility theories, none of them is the best. Therefore, we
applied all three methods to identify the one performing the best
with our data. The formula used by the monotonic method and
the linear method was –t/10 and t/[(10  t)  19], respectively.Modeling of TTO values
The main analysis in this study was modeling of the TTO values
using various linear regression models. We used three types of
dependent variables that were used in previous EQ-5D-3L ques-
tionnaire valuation studies: 1) disutility (1 minus the utility); 2)
the difference in values between “33333” and the particular state;
and 3) logarithm of disutility. Using the MVH data, Dolan found
that method 2 led to better modeling results than did method 1,
while Jo et al. [19] found that method 3 performed better than
method 1 in a valuation study in South Korea.
Four types of model speciﬁcations were estimated in our study:
1) the main effects model; 2) the N3 model; 3) the D1 model; and 4)
the “difference”model. The main effects model included 10 dummy
variables for specifying the problems in a state, with the MO2, SC2,
UA2, PD2, and AD2 terms being 1 (0) for the presence (absence) of
level 2 problems in mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression, respectively, and the MO3, SC3,
UA3, PD3, and AD3 being 1 (0) for the presence (absence) of level 3
problems in those dimensions [14]. The N3 model was model 1 plus
the N3 term, which was a dummy variable whose value was 1 if any
level 3 problems were present in a state and 0 if otherwise [15,20].
The D1 model was model 1 plus D1, I2, (I2)2, I3, and (I3)2, terms in
which D1 was the number of dimensions with problems beyond the
ﬁrst, I2 and I3 were the number of dimensions at level 2 or level 3
beyond the ﬁrst, respectively, and (I2)2 and (I3)2 were the square of I2
and I3 [21], respectively. The difference model comprised a set of
dummy variables indicating the presence of level 1 or level 2 in a
given dimension of a state, while the dependent variable was the
value difference between the state and “33333” [22].
It should be noted that the utility values may be a function of
the interactions between the main effects. Models with these
interaction terms, however, suffered from multicollinearity.
Moreover, the inclusion of a large number of ﬁrst-order inter-
action effects may introduce the risk that some become signiﬁ-
cant purely by chance [14,21]. Such interaction terms were
usually excluded from modeling analysis in previous studies.
The study was conducted at both aggregate and individual
levels. In the aggregate-level analysis, the mean values of the 97
health states were calculated and modeled using both ordinary
least square (OLS) and weighted least square (WLS, where the
number of respondents who rated a particular state was the weight)
estimators; in the individual-level analysis, the individual TTO
values from all participants were pooled and modeled using the
OLS and ﬁxed-effect (FE)/random-effect (RE) estimators. The FE/RE
models were used because each participant contributed 13 TTO
values in this analysis. In the RE model, the individual subject effect
was estimated for the intercept only, while in the FE model, the
individual subject effect was estimated for all independent varia-
bles. All statistical analyses were conducted using STATA/SE 11.2.
Given the alternative models and variables, certain criteria were
formulated to identify the best-performing model including 1)
predictive ability, that is, the difference between the observed
and the estimated values or mean absolute error (MAE), and the
number of prediction errors greater than 0.05 and 0.10, respectively;
2) the sign and signiﬁcance of regression coefﬁcients; for example,
the main effects should be positive when disutility was used as the
dependent variable and the coefﬁcients should be statistically
signiﬁcant; 3) logical consistency, speciﬁcally, if state A is superior
to state B in one or more dimensions and not inferior in any otherdimension, the estimated value for state A should be no lower than
that for state B; 4) parsimony, that is, if the performances of several
models were similar, the most parsimonious model would be
preferred [20,23]. For guiding model selection according to the ﬁrst
criteria, all models were estimated using a subset of randomly
selected two thirds of the participants and then used to predict
values for the remaining one third of the participants.Results
Logical Inconsistencies in TTO Evaluation
The way the 97 health states were assigned into eight blocks
allowed the examination of within-individual logical inconsistence
in TTO valuation for 301 pairs of health states, with an average of
38 pairs for each individual. Of the 1218 participants who did not
give all the states the same value, 813 participants (66.8%) did not
give any logically inconsistent TTO values. Poor data quality was
observed in a total of 71 participants (5.8%) who violated logical
consistency for more than four pairs of states. At the aggregate
level, the means of the 97 health states did not show any logical
inconsistency in pairwise comparison of the health states.
Sample Characteristics
Of 1222 participants who were successfully interviewed, 75 partic-
ipants were excluded because of more than four logically incon-
sistent values (N ¼ 71) or assignment of the same value to all
states (N ¼ 4). The ﬁnal sample included 1147 participants. The sex
and age distributions of participants in the ﬁnal sample were
similar to those of the Chinese population in China. The majority
of the participants in the ﬁnal sample were Han nationals (96.2%),
females (50.3%), and graduates from at least a senior high school
(82.0%). The mean age of the participants in the ﬁnal sample was
43.3 years, and the average interview time was 43.1 minutes
(median 40.0 minutes). The characteristics of participants in the
ﬁnal sample were largely similar to those who were excluded from
the study except that those excluded participants were slightly
younger and reported slightly better health status and lifestyles.
The full sociodemographic and health-related characteristics of
the ﬁnal and excluded samples are presented in Table 2.
Modeling of TTO Values
The linear transformation approach to rescaling negative values
consistently yielded smaller prediction errors than did the mon-
otonic and truncated transformation approaches regardless of the
dependent variable (disutility, the difference in values compared
with “33333,” or logarithm of disutility), model speciﬁcation (the
main effects, N3, or D1), or model estimator (OLS, FE, or RE at the
individual level, or OLS and WLS at the aggregate level) used. For
example, when disutility was regressed on the main effects terms
and the model was estimated using individual-level data with the
RE estimator, the number of health states for which the absolute
prediction error was greater than 0.05 (or 0.10) was 9, 21, and 29 (or
0, 2, and 4) when the linear, monotonic, and truncated approach
was used to transform the negative values, respectively. Hence,
the linear transformation approach was used in the ﬁnal analysis.
Models using disutility as the dependent variable performed
better than did those using the logarithm of disutility and not
worse than did those using the difference from the “33333” in
terms of predictive ability. Therefore, disutility was adopted as the
dependent variable in the ﬁnal analysis. Tables 3 and 4 present
the parameter estimates and goodness-of-ﬁt results for the main
effects, N3, and D1 models at individual level and aggregate level,
respectively. In the individual-level data analysis, the Hausman
test did not reject the null hypothesis (χ2 ¼ 6.24, P ¼ 0.7951);
Table 2 – Characteristics of participants.
Characteristic Total sample
(n ¼ 1222)
Final sample
(n ¼ 1147)
Excluded sample
(n ¼ 75)
P*
Sex 0.776
Male 49.59 49.69 48.00
Female 50.41 50.31 52.00
Age (y) 0.456
18–20 8.84 8.89 8.00
21–30 17.43 17.18 21.33
31–40 18.25 17.79 25.33
41–50 21.28 21.45 18.67
51–60 17.27 17.44 14.67
61 or more 16.94 17.26 12.00
Ethnic group 1.000
Han Chinese 97.70 96.16 97.33
Other 2.30 3.84 2.67
Self-reported EQ-5D-3L problems
Mobility 2.30 2.18 4.00 0.245
Self-care 0.33 0.35 0.00 1.000
Usual activities 1.80 1.75 2.67 0.641
Pain/discomfort 19.26 19.56 14.67 0.298
Anxiety/depression 13.03 13.45 6.67 0.091
Smoking status 0.729
Never 74.22 74.02 77.33
Occasionally 9.25 9.24 9.33
Often 12.93 12.99 12.00
Discontinued or quit 3.60 3.75 1.33
Alcohol consumption 0.790
Never 41.90 41.76 44.00
Occasionally 50.08 50.31 46.67
Often 6.55 6.54 6.67
Discontinued or quit 1.47 1.39 2.67
Physical exercise 0.650
Often 34.81 34.55 38.67
Occasionally 56.18 56.28 54.67
Never 9.01 9.16 6.67
Self-reported health states in the past month 0.727
Very good 18.33 18.05 22.67
Good 42.39 42.37 42.67
Fair 35.84 36.01 33.33
Poor 3.03 3.14 1.33
Very poor 0.41 0.44 0.00
Number of chronic conditions 0.841
0 67.51 67.13 73.33
1 23.24 23.45 20.00
2 5.89 6.02 4.00
3 2.05 2.09 1.33
4 or more 1.30 1.30 1.33
Marital status 0.267
Unmarried 26.02 25.81 29.33
Married 69.31 69.57 65.33
Separated 0.25 0.17 1.33
Divorced 1.80 1.74 2.67
Widowed 2.62 2.70 1.33
Monthly income† 0.549
r1,000 5.68 5.42 9.68
1,001–3,500 33.56 33.85 29.03
3,501–5,000 24.66 24.38 29.03
5,001–10,000 28.67 28.85 25.81
410,000 7.44 7.50 6.45
Education level 0.267
Below primary 0.74 0.70 1.33
Primary 3.61 3.58 4.00
Junior high 13.36 13.71 8.00
continued on next page
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Table 2 – continued
Characteristic Total sample
(n ¼ 1222)
Final sample
(n ¼ 1147)
Excluded sample
(n ¼ 75)
P*
Senior high/ technical 27.05 27.25 24.00
Junior college 21.80 21.14 32.00
University 25.82 25.76 26.67
Graduate and above 7.62 7.86 4.00
Belief in life after death 0.109
Yes, deﬁnitely 6.02 5.89 8.00
Yes, probably 19.29 19.86 10.67
No, probably not 19.04 18.54 26.67
No, deﬁnitely not 55.65 55.71 54.67
EQ-5D-3L, three-level EuroQol ﬁve-dimensions; RMB, Renminbi.
Note. Values are percentages.
* Comparison of sociodemographic distributions between valuation and excluded samples by chi-square test 110 or Fisher exact test, as
appropriate.
† RMB.
V A L U E I N H E A L T H 1 7 ( 2 0 1 4 ) 5 9 7 – 6 0 4 601therefore, the results of the OLS and RE estimation rather than FE
estimation were reported in Table 3. All the models estimated
using either OLS or RE regression had an MAE lower than 0.02,
with no less than 10 health states for which the absolute error in
prediction exceeded 0.1 and 0.05, respectively. None of the models
for the individual-level data (models 1–6), however, passed the
Jarque-Bera test for normality of the residuals (P o 0.001).
Results from modeling of aggregate-level data (models 7–12,
Table 4) were similar to those from modeling of individual-level
data. At the aggregate level, models estimated using OLS and
WLS regression generated similar results. Among those, the N3
model based on OLS regression (model 8) resulted in 0 and 7
health states for which the absolute error in prediction exceeded
0.1 and 0.05, respectively, and the MAE of 0.020, which was the
best prediction results among all the models tested.
Model 8 passed the Breusch-Pagan/Cook-Weisberg test for heter-
oskedasticity (χ2 ¼ 0.97; P ¼ 0.3254). There was no model misspeci-
ﬁcation as indicated by the Ramsey Regression Equation Speciﬁcation
Error Test (F ¼ 2.7; P ¼ 0.0509). It also passed the Jarque-Bera test for
normality of the residuals (χ2 ¼ 1.285; P ¼ 0.5259). Figure 1 presents
the mean observed values, predicted values, and mean errors of the
97 health states based on model 8. This model was subsequently
reestimated using randomly selected two thirds of the sample and
used to predict for the remaining one third. The Pearson’s product-
moment correlation coefﬁcient was 0.9921, the MAE was 0.027, and
the number of health states for which the absolute error was greater
than 0.1 and 0.05 was 1 and 12, respectively. Based on all these
results, model 8 was selected to estimate the values for all the 243
EQ-5D-3L health states. For instance, the value for “23221” was 1 
0.039 0.099  0.208  0.074  0.092  0  0.022 ¼ 0.466.Discussion
Economic evaluation has been increasingly used to inform
decision making in health care resources allocation. In China,
the central government has pledged to use pharmacoeconomic
evaluations to guide the pricing of new, patented drugs [24] and
the EQ-5D-3L questionnaire is endorsed as a suitable instrument
for measuring QALYs in CUA [9]. The use of this instrument in
China, however, necessitates having values for the health states
from the Chinese population. In this study, we determined the
values of the EQ-5D-3L health states from the perspective of the
Chinese people. This is the ﬁrst effort to develop standardized
utility-measuring tools for conducting economic evaluations in
the world’s most populous country. Hence, this study representsan important milestone in the development of health technology
assessment in China.
Because there is no criterion standard method for valuing
hypothetical health states, the validity of the EQ-5D-3L values
estimated in our study cannot be directly assessed. Nevertheless,
the result that more severe health problems were associated with
greater disutility values exhibited in all linear regression models
support the construct validity of the utility values. Also, the EQ-
5D-3L values as predicted by model 8 are highly correlated with
those estimated from other populations [14,15,19–22,25,26] using
similar methods (see Appendix 1 in Supplemental Materials
found at http://dx.doi.org/10.1016/j), indicating convergent con-
struct validity. Moreover, the modeling results are similar to
those from previous EQ-5D-3L valuation studies. The data ﬁt all
the model speciﬁcations used in previous valuation studies well,
and the best model ﬁt and the range of predicted values in this
study were similar to those in previous studies (see Appendix 1 in
Supplemental Materials found at http://dx.doi.org/10.1016/j.jval.
2014.05.007). These similarities may also be treated as evidence
for the validity of the value set developed.
A prominent feature of the present study is direct valuation of
40% of the 243 EQ-5D-3L health states. By adopting the Paris
protocol, we valued a total of 97 EQ-5D-3L states; in contrast,
most previous studies used the MVH protocol to value only 42
EQ-5D-3L health states. The Paris protocol was developed by Paul
Kind, the main investigator of the MVH study, to replace the 12-
year-old MVH protocol. The main feature of the Paris protocol is
to value an increased number of EQ-5D-3L states [16]. Theoret-
ically, the more states valued directly, the fewer states for which
values have to be estimated purely on the basis of modeling (i.e.,
smaller interpolation space) and hence higher prediction accu-
racy. Before the present study, the Paris protocol was success-
fully implemented in South Korea [15]. One advantage of using
the Paris protocol is the opportunity to model the means of the
valued health states. This would not be optimal for studies using
the MVH because only 17% of the 243 states were valued.
Interestingly, the model based on aggregate-level data outper-
formed the model based on individual-level data in both the
Korean study and the present study, suggesting that the former
may be a better modeling approach than the latter. The better
model ﬁt of the aggregate-level data should be due to the
elimination of the individual-level data variability. This was not
a disadvantage, however, because the purpose of the modeling
was to predict the population values of the health states but not
the values of individual respondents. Rather, the aggregate-level
modeling could be an advantage as the OLS algorithm is
Table 3 – Coefﬁcient estimates and ﬁt statistics of individual-level models based on OLS and RE regression.
Variable OLS RE
(1) Main effects (2) N3 (3) D1 (4) Main effects (5) N3 (6) D1*
Coefﬁcient SE† Coefﬁcient SE† Coefﬁcient SE† Coefﬁcient SE† Coefﬁcient SE† Coefﬁcient SE
Constant 0.044 0.007 0.041 0.007 0.042 0.008 0.041 0.008
MO2 0.099 0.006 0.097 0.006 0.139 0.007 0.096 0.005 0.095 0.005 0.136 0.009
MO3 0.252 0.007 0.249 0.007 0.311 0.014 0.252 0.006 0.251 0.006 0.304 0.012
SC2 0.103 0.006 0.104 0.006 0.144 0.008 0.099 0.005 0.100 0.005 0.139 0.009
SC3 0.214 0.007 0.212 0.007 0.272 0.016 0.210 0.006 0.208 0.006 0.260 0.013
UA2 0.075 0.006 0.073 0.006 0.113 0.007 0.081 0.005 0.079 0.005 0.119 0.009
UA3 0.201 0.007 0.197 0.007 0.258 0.013 0.208 0.006 0.205 0.006 0.257 0.011
PD2 0.093 0.006 0.092 0.006 0.132 0.008 0.100 0.005 0.099 0.005 0.138 0.009
PD3 0.244 0.007 0.242 0.007 0.301 0.016 0.247 0.007 0.245 0.007 0.296 0.013
AD2 0.087 0.006 0.086 0.006 0.125 0.008 0.082 0.004 0.082 0.004 0.120 0.009
AD3 0.214 0.007 0.210 0.007 0.269 0.014 0.213 0.006 0.211 0.006 0.261 0.012
N3 0.014‡ 0.008 0.008§ 0.007
D1 0.037 0.013 0.037 0.011
I2 0.006§ 0.016 0.001‡ 0.012
(I2)2 0.002§ 0.004 0.0001‡ 0.003
I3 0.040 0.014 0.026‡ 0.010
(I3)2 0.004|| 0.002 0.003‡ 0.002
Adjusted R2 0.4789 0.4789 0.833 0.6399 0.6399
MAE 0.0197 0.0197 0.0189 0.0198 0.0198 0.0191
No. (of 97) 40.05 9 8 8 8 9 6
No. (of 97) 40.1 0 0 0 0 0 0
Note. P o 0.01 for all regression coefﬁcients unless otherwise stated.
MAE, mean absolute error; OLS, ordinary least square; RE, random effects; SE, standard error.
* Random-effects model using maximum likelihood estimator.
† Heteroskedasticity-robust standard error.
‡ 0.05 o P ≤ 0.1.
§ P 4 0.1.
|| 0.01 ≤ P ≤ 0.05.
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Table 4 – Coefﬁcient estimates and ﬁt statistics of aggregate-level models based on OLS and WLS regression.
Variable OLS WLS
(7) Main effects (8) N3 (9) D1 (10) Main effects (11) N3 (12) D1
Coefﬁcient SE Coefﬁcient SE Coefﬁcient SE* Coefﬁcient SE Coefﬁcient SE Coefﬁcient SE*
Constant 0.044 0.010 0.039 0.010 0.044 0.010 0.041 0.010
MO2 0.099 0.008 0.099 0.008 0.139 0.009 0.099 0.008 0.097 0.008 0.139 0.009
MO3 0.251 0.008 0.246 0.009 0.310 0.014 0.252 0.008 0.249 0.008 0.311 0.014
SC2 0.103 0.007 0.105 0.007 0.145 0.009 0.103 0.007 0.104 0.007 0.144 0.009
SC3 0.213 0.008 0.208 0.008 0.271 0.016 0.214 0.008 0.211 0.008 0.272 0.016
UA2 0.075 0.008 0.074 0.008 0.113 0.008 0.075 0.008 0.073 0.008 0.113 0.008
UA3 0.200 0.008 0.193 0.009 0.256 0.014 0.201 0.008 0.197 0.008 0.258 0.015
PD2 0.093 0.007 0.092 0.007 0.133 0.009 0.093 0.007 0.092 0.007 0.133 0.009
PD3 0.243 0.008 0.236 0.008 0.299 0.014 0.244 0.008 0.242 0.008 0.301 0.014
AD2 0.088 0.008 0.086 0.007 0.126 0.009 0.087 0.007 0.086 0.007 0.125 0.009
AD3 0.213 0.008 0.205 0.008 0.268 0.014 0.214 0.008 0.210 0.008 0.269 0.014
N3 0.022† 0.010 0.015‡ 0.010
D1 0.036 0.012 0.037 0.012
I2 0.008‡ 0.018 0.006‡ 0.018
(I2)2 0.002‡ 0.004 0.002‡ 0.004
I3 0.038† 0.017 0.040† 0.016
(I3)2 0.004‡ 0.003 0.004§ 0.002
Adjusted R2 0.9874 0.9879 0.9979 0.9910 0.9911 0.9984
MAE 0.0210 0.0204 0.0205 0.0209 0.0205 0.0204
No. (of 97) 40.05 8 7 8 9 8 8
No. (of 97) 40.1 0 0 0 0 0 0
Note. P o 0.01 for all regression coefﬁcients unless otherwise stated.
MAE, mean absolute error; OLS, ordinary least square; SE, standard error; WLS, weighted least square.
* Heteroskedasticity-robust standard error.
† 0.01 ≤ P ≤ 0.05.
‡ P 4 0.1.
§ 0.05 o P ≤ 0.1.
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Fig. 1 – Observed values, predicted values, and mean errors
of 97 health states. EQ-5D, EuroQol ﬁve-dimensions; TTO,
time trade-off.
V A L U E I N H E A L T H 1 7 ( 2 0 1 4 ) 5 9 7 – 6 0 4604sufﬁcient for model estimation. Therefore, this study supports
the use of the Paris protocol and the conduct of aggregate-level
modeling in future EQ-5D-3L valuation studies.
In this study, we excluded participants whose valuations
violated the utility theory from our analysis for estimating the
social values of the EQ-5D-3L states. Logically inconsistent values
suggested that those participants failed to either understand or
concentrate on the valuation questions. Therefore, as some of the
previous health state valuation studies did [19,27], we excluded
some of those participants who gave multiple logically incon-
sistent responses. It should be noted that many EQ-5D valuation
studies did not exclude logically inconsistent values and that
Lamers et al. [28] found that inconsistent data did not have
important effects on the modeling results when estimating the
EQ-5D values. Nevertheless, we elected to exclude inconsistent
participants to achieve more accurate and reliable predictions.
We postulated that the main reason for the logical inconsistency
in our study was poor concentration because those participants
were relatively young and well educated.
The main limitation of the present study was the sampling
method used. We were unable to conduct probabilistic sampling
because of resource constraints. All participants of the study were
recruited from big cities. Because of the socioeconomic differences
between cities and rural areas in China, health preferences of
residents in cities and rural areas may differ. Also, the majority of
the participants were of Han nationality; minority nationalities in
China who account for 9% of the population may have different
health preferences. Future health state valuation studies should
target rural and minority populations in the country.
Despite the limitations, the EQ-5D-3L value set we developed
using a general Chinese population sample provides health
services researchers and policymakers with a convenient tool
for conducting economic evaluation of health technologies in
China. This study is the ﬁrst attempt to develop a standardized
instrument for quantifying QALYs in China.
Source of ﬁnancial support: The research was supported by
the National Natural Science Foundation of China (grant
no.71273015) and a research grant from Guangzhou (China)
Pharmaceuticals Corporation.Supplemental Materials
Supplemental material accompanying this article can be found in
the online version as a hyperlink at http://dx.doi.org/10.1016/j.jval.2014.05.007. or, if a hard copy of article, at www.valuein
healthjournal.com/issues (select volume, issue, and article).
R E F E R E N C E S[1] Lamers LM, McDonnell J, Stalmeier PFM, et al. The Dutch tariff: results
and arguments for an effective design for national EQ-5D valuation
studies. Health Econ 2006;15:121–32.
[2] Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status
classiﬁcation systems: health utilities index. Pharmacoeconomics
1995;7:490–502.
[3] Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-
attribute utility functions for the health utilities index mark 3 system.
Med Care 2002;40:113–28.
[4] Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53–72.
[5] Herdman M, Gudex C, Lloyd A, et al. Development and preliminary
testing of the new ﬁve-level version of EQ-5D (EQ-5D-5L). Qual Life Res
2011;20:1727–36.
[6] Brazier J, Roberts J, Deverill M. The estimation of a preference-based
measure of health from the SF-36. J Health Econ 2002;21:271–92.
[7] Bailey H, Kind P. Preliminary ﬁndings of an investigation into the
relationship between national culture and EQ-5D value sets. Qual Life
Res 2010;19:1145–54.
[8] Knies S, Evers SM, Candel MJ, et al. Utilities of the EQ-5D: transferable
or not? Pharmacoeconomics 2009;27:767–79.
[9] China guidelines for pharmacoeconomic evaluations (2011). 2011.
Available from: http://www1.gsm.pku.edu.cn/UserFiles/File/
543a4421-b610-471b-bada-47d511160cfa.pdf. [Accessed April 9, 2011].
[10] Wang H, Kindig DA, Mullahy J. Variation in Chinese population health
related quality of life: results from a EuroQol study in Beijing, China.
Qual Life Res 2005;14:119–32.
[11] Luo N, Chew LH, Fong KY, et al. Validity and reliability of the EQ-5D
self-report questionnaire in Chinese-speaking patients with rheumatic
diseases in Singapore. Ann Acad Med Singapore 2003;32:685–90.
[12] Chang TJ, Tarn YH, Hsieh CL, et al. Taiwanese version of the EQ-5D:
validation in a representative sample of the Taiwanese population.
J Formos Med Assoc 2007;106:1023–31.
[13] Ma J. China Statistical Yearbook 2010. Beijing, China: China Statistics
Press, 2010.
[14] Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ-5D population
value set: the case of Japan. Health Econ 2002;11:341–53.
[15] Lee YK, Nam HS, Chuang LH, et al. South Korean time trade-off values
for EQ-5D health states: modeling with observed values for 101 health
states. Value Health 2009;12:1187–93.
[16] Kind P. A Revised Protocol for the Valuation of Health States Deﬁned by
the EQ-5D-3L Classiﬁcation System: Learning the Lessons from the MVH
Study. York: Centre for Health Economics, University of York, 2009.
[17] Szende A, Oppe M, Devlin N. EQ-5D Value Sets: Inventory, Comparative
Review and User Guide. Dordrecht: Springer, 2007.
[18] Lamers LM. The transformation of utilities for health states worse than
death: consequences for the estimation of EQ-5D value sets. Med Care
2007;45:238–44.
[19] Jo MW, Yun SC, Lee SI. Estimating quality weights for EQ-5D health
states with the time trade-off method in South Korea. Value Health
2008;11:1186–9.
[20] Dolan P. Modeling valuations for EuroQol health states. Med Care
1997;35:1095–108.
[21] Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states:
development and testing of the D1 valuation model. Med Care
2005;43:203–20.
[22] Dolan P, Roberts J. Modeling valuations for EQ-5D health states: an
alternative model using differences in valuations. Value Health
2002;40:442–6.
[23] Yang Y, Brazier J, Tsuchiya A, Coyne K. Estimating a preference-based
single index from the Overactive Bladder Questionnaire. Value Health
2009;12:159–66.
[24] View on deepening the health care system reform by CPC Central
Committee and the State Council. 2009. Available from: http://www.gov.
cn/jrzg/2009-04/06/content_1278721.htm. [Accessed March 17, 2009].
[25] Jelsma J, Hansen K, De Weerdt W, et al. How do Zimbabweans value
health states? Popul Health Metr 2003;1:1–10.
[26] Augustovski FA, Irazola VE, Velazquez AP, et al. Argentine valuation of
the EQ-5D health states. Value Health 2009;12:587–96.
[27] Montejo AL, Correas-Lauffer J, Maurino J, et al. Estimation of a
multiattribute utility function for the Spanish version of the TooL
questionnaire. Value Health 2011;14:564–70.
[28] Lamers LM, Stalmeier PF, Krabbe PF, et al. Inconsistencies in TTO and
VAS values for EQ-5D health states. Med Decis Making 2006;26:173–81.
